Clinical Trial

Alveolar Macrophage Programming Following Endotoxin Exposure

Recruiting
View on ClinicalTrials.gov →
Summary
The histologic hallmarks of lung inflammation include accumulation of inflammatory cells in the airspaces and interstitium, injury to alveolar epithelial and endothelial cells, loss of epithelial-capillary integrity and accumulation of edema fluid in the interstitium and airspaces. Accordingly, for alveolar repair to occur inflammation must be halted, debris and inflammatory cells removed, injured tissue cells replaced, and capillary barrier function re-established. Macrophages are key players in all of these. Here the investigators hypothesize that resident alveolar macrophages and recruited macrophages serve completely different functions, acting independently (i.e. division of labor) yet cooperatively (synergism).
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2019-02-27; most recent amendment 2025-05-02.
Status change: Not Yet Recruiting → Recruiting 2019-08-19
Trial Details
NCT Number NCT03859050
Lead Sponsor National Jewish Health
Conditions ARDS, Human
Enrollment 25 participants
Start Date 2019-03-18
Primary Completion 2029-07 (estimated)
Study Completion 2032-07 (estimated)
Updated on ClinicalTrials.gov 2025-05-06